In what the U.S. Department of Justice called on Thursday the largest health care fraud enforcement action in the agency’s history, more than 400 defendants nationwide have been charged with defrauding taxpayers of $1.3 billion.
The takedown—which is the largest enforcement action of its kind in terms of number of defendants, though not in terms of dollars— is a strong reflection of one of the new announced priorities at the DOJ under the Trump administration and new U.S. Attorney General Jeff Sessions: drugs, particularly opioid painkillers and other prescription narcotics.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
